September 2021

Cardiologists performing fewer imaging exams | Working together with pharmacies | AFib & COPD ()
September in Review: Recalls hit the industry | Intermittent fasting | The world’s top 250 hospitals for cardiology ()
Key approvals for Abbott & Medtronic | Just 3.6% of TAVR procedures performed by women | HF & cirrhosis ()
A new technique for evaluating heart attacks | TAVR vs. SAVR for CKD patients | 'A major public health challenge' ()
Vascular & Endovascular: Monitoring high-risk patients | Portable MRI tech | Modern device thrombectomy ()
Emergency kits recalled | FDA investigating LAAO outcomes | Next-day discharge after TAVR ()
News Alert: FDA now investigating potential differences in LAAO outcomes among men & women ()
FDA approves ready-to-use injections for hypertension | Cardiologist helps employees fight vaccine mandate ()
Best of the Week: Cardiologist pays $6.75M | 3 big recalls hit cardiology | Intermittent fasting & heart disease ()
The world's top 250 hospitals for cardiology | Catheters recalled after 8 injuries | Tissue valves gain FDA approval ()
News Alert: FDA announces recall of 25,000 catheters after 167 complaints, 8 injuries ()
Heart Failure: FDA policy could boost care for millions | Dapagliflozin for HFpEF | 'This pandemic is not over' ()
1 in 10 young adults with left-sided breast cancer develop heart disease | PCI for late-presenting STEMI patients ()
Acute Coronary Syndromes: Flu shots after heart attacks | Marijuana use & heart health | The benefits of coffee ()
Boston Scientific's $269M acquisition | Valve-in-valve TAVR | Cardiologist tackles big topics with new book ()
Economics & Policy: Cardiologist salaries stay competitive | FDA announces new warnings for multiple meds ()
Breaking News: Medtronic recalls embolization devices after 2 deaths, 10 serious injuries ()
Medtronic recalls embolization devices after 2 deaths | New TAVR system gains FDA approval | CCTA & atherosclerosis ()
Interventional & Surgery: Fraud allegations | Dual-layered stents | MCS during high-risk PCI | New CAS data ()
Cardiologist pays $6.75M to resolve fraud allegations | More lots of losartan recalled | $25.5B in funding ()
Best of the Week: Cardiologists oppose key CMS proposals | Full-time vs. part-time physicians | Dapagliflozin & HFpEF ()
Prevention & Risk Reduction: FDA issues warnings for 'fraudulent claims' | Hypertension cases skyrocket ()
Updated FDA policy could help up to 1.8 million HF patients | Hydroxyurea & SCA ()
Structural Heart Disease: Comparing LAA occluder devices | LAAO outcomes among women | TEER vs. surgery ()
Cardiologists oppose 2 key CMS proposals | AI model could improve AVR timing ()
DOACs vs. warfarin | 12-month data on dual-layered stents | Sleep patterns & AFib | iRhythm's new CEO ()
Imaging & Physiology: Portable MRI tech | Echocardiography-guided LAAC improves outcomes ()
Dapagliflozin improves HFpEF symptoms | Delayed PDL after LAAC | 'No-touch' vein harvesting ()
Cardiologists urge CMS to reconsider proposal | High total cholesterol levels & COVID-19 ()
Best of the Week: ()
COVID-19: The pandemic's impact on cardiology | A potential new treatment | 55 long-term side effects ()
10 companies warned for making ‘fraudulent claims’ about diabetes supplements | Efpeglenatide & CVD ()
News Alert: FDA, FTC warn 10 companies for making ‘fraudulent claims’ about unapproved diabetes supplements ()
Marijuana use & heart attacks | Why severe COVID-19 is so common in people with diabetes | Valve-in-valve TMVR ()
Practice Management: Aggressive BP management | A promising COVID treatment | Burnout & exhaustion in healthcare ()
A key improvement in PCI care | TEER vs. surgery when treating secondary MR | Stroke & epilepsy ()
TAVR: Valve durability after 5 years | 3 conditions linked to a higher stroke risk | Paravalvular leak still an issue ()
Monitoring for AFib fails to reduce stroke risk | Pregnant patients with 'leaky' heart valves | High-risk PCI ()
Best of the Week: FDA announces new warnings | Salaries stay strong | 55 long-term side effects of COVID-19 ()
Heart Rhythm: Breathing issues prior to cardiac arrest | Ablation & AFib | Drones vs. ambulances ()
How COVID-19 has impacted salaries | Coffee & CVD | Amulet vs. Watchman | Abbott's new acquisition ()
FDA updates warnings due to heart issues | Valve durability after TAVR | ASCVD & statin use | Echo-guided LAAC ()
News Alert: FDA announces new warnings for multiple medications due to risk of heart issues, stroke and death ()